Speakers

He also developed vaccines against chikungunya, Zika, influenza, rabies, plague, Nipah, yellow fever, and many other emerging infectious diseases. He has expertise in vaccine design and optimization of antigen expression, and has used mRNA, viral vectors, live attenuated, and recombinant protein expression systems to develop novel vaccines. Dr. Osorio was also the Vice-President of Research and Vice-President of Government Affairs for the Vaccine Business Division of Takeda Pharmaceuticals. Dr. Osorio worked for the World Mosquito Program and created business opportunities to implement Wolbachia as a strategy for vector control in several Latin American countries. His industry career also included positions at Heska Corporation (Ft. Collins, CO), Merial LTD (Athens, GA), and Chiron-Powderject Vaccines (Madison, WI). He has more than 35 years of research and industry experience, with over 200 scientific publications in international journals and 33 patents.